Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU5E-10P ("RNA, U5E small nuclear 10, pseudogene") is a non-coding RNA gene classified as a **pseudogene** of the U5E small nuclear RNA gene family. The locus is present in the human genome, but the gene is annotated as a pseudogene, indicating that it is not believed to produce a functional snRNA product. Unlike functional U5 small nuclear RNAs, which are essential components of the major spliceosome and are directly involved in pre-mRNA splicing, RNU5E-10P does not contribute to spliceosomal activity. There is no evidence supporting its role as a therapeutic target, no known drug interactions, and no established disease relevance[1][7]. Its biological impact, if any, would be indirect—potentially through regulatory effects observed in some other pseudogenes, but such roles have not been reported for RNU5E-10P. **General context about snRNA pseudogenes:** Pseudogenes are genomic elements closely resembling known genes but typically lack the ability to encode a functional product. Some pseudogenes transcribe RNA, and, in rare cases, have been implicated in gene regulation—for example, by acting as decoys for microRNAs or generating regulatory RNAs[4][8]. However, the vast majority, including RNU5E-10P, have no evidence for functional roles, druggability, or disease association relevant to therapeutic targeting. **Summary:** RNU5E-10P is a small nuclear RNA pseudogene with no known function, not used as a therapeutic target, and not implicated in disease or drug interactions. It is properly named and not misspelled[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U5E small nuclear 10, pseudogene (RNU5E-10P).